Medifast, Inc. (0K05.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 117.17M |
| Enterprise Value | 44.65M |
| P/E Ratio | -6.05 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.35 |
| Price/Book Ratio | 0.61 |
| Enterprise/Revenue | 0.19 |
| Enterprise/EBITDA | 10.58 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.06 |
| Operating Margin | -0.04 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.1 |
Income Statement
| Revenue | 385.79M |
| Revenue/Share | 31.45 |
| Gross Profit | 275.19M |
| EBITDA | -3.71M |
| Net Income | -18.67M |
| Diluted EPS | -1.7 |
Balance Sheet
| Total Cash | 168.95M |
| Total Cash/Share | 15.35 |
| Total Debt | 16.1M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 4.8 |
| Book Value Per Share | 17.96 |
Price History
| 52-Week Change | -13.04 |
| 52-Week High | 109.46 |
| 52-Week Low | 10.96 |
| Moving Average 50 Days | 51.19 |
| Moving Average 200 Days | 72.86 |
Statistics
| Average Volume | 450 |
| Shares Outstanding | 11.97M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
